Skip to content

Aimscreen Multidrug 12 40135

by Germaine Laboratories, Inc.

Aimscreen Multidrug 12 40135 is a Class II device made by Germaine Laboratories, Inc., listed in FDA GUDID since 12 May 2016 (UDI-DI 00695684401351), registry data as of 22 Oct 2026.

Listed FDA GUDID listing, no authorization on record

Valid until

Not applicable

Database listing, no authorization

FDA recalls

Not checked

No FDA submission to match recalls against

Documents

None

No authorization documents

Trust

Unverified

Source GUDID, synced 22 Oct 2026.

Regulatory status

as of registry sync 22 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesGUDID listing Number00695684401351 UDI-DI Date12 May 2016ListedStatusListed GUDID: in commercial distribution

Official records

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — GUDID listing Listed

Specification

GUDID

Trade name
Aimscreen Multidrug 12
Generic name
Tricyclic antidepressant IVD, kit, rapid ICT, clinical
Model / reference
40135
Primary DI / UDI-DI
00695684401351
FDA product code
LFG, JXN, DIS, LCM, JXM, DKZ, DJG, LAF, DIO, LDJ
GMDN term
Tricyclic antidepressant IVD, kit, rapid ICT, clinical
Device class
Class II
Regulation number
862.3910, 862.3700, 862.3150, 862.3170, 862.3100, 862.3650, 862.3610, 862.3250, 862.3870
GUDID distribution status
In Commercial Distribution

Related devices

Category: Cannabinoid/cannabinoid metabolite IVD, kit, rapid ICT, clinicalCocaine/cocaine metabolite IVD, kit, rapid ICT, clinicalOpiate/opiate metabolite IVD, kit, rapid ICT, clinicalAmphetamine-specific IVD, kit, rapid ICT, clinical

Similar devices

Other devices filed under FDA product code LFG (Radioimmunoassay, Tricyclic Antidepressant Drugs).

Other devices from Germaine Laboratories, Inc.

See all devices from Germaine Laboratories, Inc. →

Properties

  • Single use
  • Prescription use
  • Lot / batch number
  • Expiration date
Other properties (11, all answered No)